LYVE1 and neoplasm: In our eight mRNAsi based signature, high expression of RGS16, LYVE1, hnRNPC, ANP32A, and AIMP1 are correlated with a high risk of death as these genes focus in promoting cell proliferation and tumor progression, similar to stem cells.